It's a big day for pipeline progress...or not. Late Friday, Merck and Schering-Plough announced that the Food and Drug Administration won't approve their combo Claritin-Singulair combo pill for allergies.    Read More

Schering-Plough beat the Street by a surprising 16 cents per share and the beaten-down shares are rallying. In an exclusive CNBC interview Wednesday morning, Chairman and CEO Fred Hassan explained how the company was able to blow away estimates...   Read More

Given investor reaction to the Vytorin/Zetia news yesterday, you might draw the conclusion the huge cholesterol drug franchise might be doomed. Sure, analysts say, prescriptions and sales are gonna go down some more, but they're not going to zero.    Read More

Following are the day’s biggest winners and losers. Find out why shares of Fortune Brands and Northwest Airlines popped while Thornburg Mortgage  and Cal-Maine Foods dropped.   Read More

The Dow, S&P and Nasdaq are just points away from breaking their monthly losing streaks at 4 straight months of losses. Here's what they would need to rally today to have their first positive month since October:   Read More